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Clinical Investigation / Araştırma
PRECIS: The correlation between dysmorphic uterus and infertility still remains enigmatic. We evaluated the reproductive outcomes of office 
hysteroscopic metroplasty in unexplained infertile women with dysmorphic uterus. Our study demonstrated that office hysteroscopic metroplasty of 
a dysmorphic uterus might improve fertility, particularly in unexplained infertility patients with dysmorphic uterus.
Öz
Giriş: Dismorfik uterus ve infertilite arasındaki ilişki hala bilinmemektedir. Dismorfik uterusu ve açıklanamayan infertilite tanısı olan hastalarda ofis 
histeroskopik metroplastinin üreme üzerine olan sonuçlarını değerlendirdik.
Gereç ve Yöntemler: Bu retrospektif kohort çalışmada, kliniğimizde Ocak 2013-Aralık 2016 tarihleri arasında bipolar ofis histeroskopik metroplasti 
uygulanan 272 dismorfik uterus ve açıklanamayan infertil hastalar değerlendirilmiştir. Bu hastaların 162 tanesi primer infertil 110 tanesi sekonder infertildir.
Bulgular: Primer infertil olan hastalarda hsiteroskopik metroplasti sonrası klinik gebelik oranı %45,68 (74/162), sekonder infertil grupta %55,65 (61/110) 
olarak bulunmuştur. Her iki grupta metroplasti sonrası canlı doğum oranı %38,9 (63/162) ve %49 (54/110)’dur. Düşük oranı ve özellikle dış gebelik 
oranı sekonder infertil grupta dramatik olarak azalmıştır [düşük oranı; %84,5’den (93/110) %9,8’e (6/61) düşmüş ve ektopik gebelik %15,5’den (17/110) 
%1,6’ya (1/61) düşmüştür) (p=0,01)].
Sonuç: Dismorfik uteruslu infertil kadın fertilitesini artırmak için ofis histeroskopi yoluyla opere edilmelidir. Müllerian anomaliler üreme sonuçlarına 
olumsuz etkileri olmaktadır. Dismorfik uterusun histeroskopik metroplasti ile düzeltilmesi bizim çalışma grubumuzda özellikle atlanmış uterin faktör 
olarak infertilite problemini de düzeltebilecektir. Ofis histeroskopi bu işlemin non-invaziv alternatifidir.
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Abstract
Objective: The correlation between dysmorphic uterus and infertility still remains enigmatic. We evaluated the reproductive outcomes of metroplasty via 
office hysteroscopy in unexplained infertile women with dysmorphic uteri. 
Materials and Methods: In this retrospective cohort study, metroplasty via office hysteroscopy using a bipolar system was performed to 272 women with 
unexplained infertility with dysmorphic uteri from January 2013 to January 2016. Of all the patients, 162 had primary infertility, and 110 had secondary 
infertility. 
Results: In the primary infertility group, the clinical pregnancy rate was 45.68% (74/162) and the live birth rate was 38.9% (63/162), and in the secondary 
infertility group, the clinical pregnancy rate was 55.45% (61/110) and the live birth rate was 49% (54/110) after metroplasty. In the secondary infertility 
group, the miscarriage rate and especially the ectopic pregnancy rate declined dramatically [from 84.5% (93/110) to 9.8% (6/61) and from 15.5% (17/110) 
to 1.6% (1/61), respectively] (p<0.01). 
Conclusion: Reproductive outcome can be impaired by Müllerian anomalies, hence, infertile women with dysmorphic uteri should undergo hysteroscopy 
to improve reproductive outcomes. Our study demonstrated that office hysteroscopic metroplasty of a dysmorphic uterus might improve fertility, 
particularly in patients with unexplained infertility with dysmorphic uteri, which was an ignored factor previously. Office hysteroscopy is an alternative 
option in terms of non-invasive procedure.
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Introduction
A dysmorphic uterus, which was formerly known as “T-shaped 
uterus” in the American Fertility Society classification of 
anomalies of the Müllerian duct, is denoted as a second-
class (Class U1) uterine anomaly in the European Society 
of Human Reproduction and Embryology (ESHRE) and the 
European Society for Gynaecological Endoscopy (ESGE) 
(ESHRE/ESGE) consensus on the classification of congenital 
genital tract anomalies, and it leads to poor reproductive and 
obstetric outcomes(1,2). Although the prevalence of dysmorphic 
uterus is not yet known, the reproductive performance 
of a dysmorphic uterus after hysteroscopic metroplasty is 
poorly documented; only five trials have been reported to 
date(3-7). In the past, operative hysteroscopy for metroplasty 
was used to expand the uterine cavity; currently, office 
hysteroscopy with a bipolar system is used, which appears 
to have minimally invasive effects, thus making it feasible 
for metroplasty(7). The encouraging results of the case series 
of 114 women remain in small numbers in the literature(3-7). 
The correlation between dysmorphic uterus and infertility 
still remains enigmatic. No study has definitely defined such 
a uterus as being the primary reason for infertility. Although 
the poor obstetric outcomes of Müllerian anomalies are well-
known issues, their reproductive performance in terms of 
infertility has been relatively ignored. Nevertheless, the lesser 
expansion of a unicornuate uterus is seen as the cause for 
infertility. The relationship between a dysmorphic uterus and 
infertility is not clarified exactly in the literature due to the 
absence of evidence on this topic. The aim of our study was 
to evaluate the effectiveness of hysteroscopic metroplasty on 
reproductive outcome in women with unexplained infertility 
with dysmorphic uteri. 
Materials and Methods
This retrospective study was conducted at Başkent University, 
Adana Dr. Turgut Noyan Practice and Research Hospital, 
Clinic of Obstetrics and Gynecology, Division of Reproductive 
Medicine and In Vitro Fertilization (IVF) Unit. Records 
of women who underwent hysteroscopic metroplasty for 
dysmorphic uterus with unexplained infertility from January 
2013 to January 2016 were investigated. Mild and/or severe 
male infertility factor, diminished ovarian reserve, history of 
endometriosis and/or endometrioma, and tubal pathologies, 
including bilateral tubal obstruction or hydrosalpinx were 
excluded and eligible women with unexplained infertility 
were analyzed. All of the included women were assessed in 
two groups as primary and secondary infertility. Institutional 
review board approval This study was approved by Başkent 
University Institutional Review Board and Ethics Committee 
approval (KA: 17/151-A) and supported by Başkent University 
Research Fond was obtained for this retrospective cohort 
study. 
Pre-operative diagnosis 
Infertile couples were admitted to Başkent University Division 
of Reproductive Medicine and IVF Unit. Medical history and 
ovarian reserve measured using the antral follicle count were 
evaluated, and hysterosalpingography (HSG) for the uterine 
cavity and tubal patency and sperm analysis were conducted. 
Unexplained infertility was defined as follows: unprotected 
intercourse for at least 1 year without conceiving with a 
normal ovarian reserve (i.e., antral follicle count over 4 in at 
least one functioning ovary with a regular menstrual cycle) 
and bilateral tubal patency observed on HSG and normal 
sperm analysis based on the World Health Organization 
2010 criteria(8). Dysmorphic uterus, formerly known as 
“T-shaped uterus,” was defined as a condensed lateral side 
uterine cavity observed using a properly performed HSG, in 
which the traction to the uterus was sufficient to expose the 
normal plain of the uterine cavity (Picture 1). The schematic 
view of the uterus revealed a T-shape, and the angle of the 
narrowed side wall was almost 90° (Picture 1). We were 
unable to perform 3D ultrasonography owing to the lack of 
this technology in our institution. There was no history of 
diethylstilbestrol (DES) exposure owing to the absence of 
DES use in Turkey. We think that the relationship between 
DES exposure and dysmorphic uterus remains speculative. 
Another issue associated with dysmorphic uterus class U1b, 
which is the infantile type, was that it could not be evaluated 
using HSG. This was a limitation of HSG. However, we did 
not experience any lateral wall perforation.
Operation
Sedation with proper a dosage of propofol and midazolam 
was applied to the women. After vaginal scrubbing with 
a povidone-iodine solution, the office hysteroscope was 
inserted in to the uterine cavity using a non-touch technique. 
Office hysteroscopy was performed at the early follicular 
phase (days 6-14) using a 5 mm diameter continuous-flow 
hysteroscope with an oval profile and a 30° fore-oblique 
telescope and a 5-Fr operating channel (Office Continuous 
Flow Operative Hysteroscopy ‘size 5’; Karl Storz, Tuttlingen, 
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Picture  1. Preoperative and postoperative hysterosalpingography 
image
HSG: Hysterosalpingography
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Germany). Cavity distension was induced using an electronic 
irrigation and aspiration system (Endomat; Karl Storz, 
Tuttlingen, Germany) with NaCl 0.9%. A stable intrauterine 
pressure of ~40 mm Hg was obtained by setting the flow rate 
to 220-350 mm Hg; the negative pressure suction was set 
at 0.2 bar, and the pressure of irrigation was set at 100 mm 
Hg. After the evaluation of the uterine cavity, the lateral side 
walls were cut using a Bipolar Versapoint System (Gynecare 
Versapoint Bipolar Electrosurgery System, Ethicon, US) until 
the tubal orifice was visible from the isthmus. The video can 
be viewed at https://youtu.be/wVh9m0dxB2I. The operations 
were performed by four experienced surgeons. At the end 
of the operation, no anti-adhesive gel and/or intrauterine 
balloon was used. We did not record our operation duration; 
nevertheless, the mean duration of the operations was ~5 
minutes. 
Post-operative approach
After the operation, the patients were discharged on the same 
day. The patients were prescribed 2 mg estradiol valerate oral 
estrogen support for 3 weeks (Cyclo-progynova tb, Bayer, 
Turkey). After 2 menstrual cycles, HSG was repeated for the 
evaluation of the newly formed uterine cavity (Picture 1). 
All patients were counseled to prevent them from conceiving 
until the second HSG. After evaluation of the new cavity using 
the second HSG, all patients were advised to try to conceive 
without assisted reproductive technology (ART) support for 
at least 1 year.
Follow-up for the evaluation of reproductive outcomes
The reproductive outcomes were recorded using the delivery 
registry from our hospital database and via telephone 
interviews. Clinical pregnancy (CP) was defined as pregnancy 
diagnosed through ultrasonographic visualization of one or 
more gestational sacs or a positive blood human chorionic 
gonadotropin test result. The live birth rate (LBR) was noted 
as the delivery of at least one live born baby after 24 complete 
weeks of gestational age. The spontaneous abortion rate was 
defined as the spontaneous loss of a CP before 20 weeks of 
completed gestation. The delivery rate ending with live births 
at full term (37 weeks’ gestation) was also recorded. 
Statistical Analysis
The data are expressed as mean ± standard deviation. The 
baseline differences between the groups were analyzed using 
Student’s t-test. Pearson’s chi-square test and Fisher’s exact 
test were used to compare the ratios between the groups. Time 
to pregnancy after metroplasty was measured using Kaplan-
Meier survival analysis. A p value of <0.05 was considered 
statistically significant. The data were analyzed using the 
SPSS for Windows (version 23.0; SPSS, Inc., Chicago, IL).
Results
During the 3-year study period, 685 office hysteroscopies 
for dysmorphic uterus were performed to 272 women with 
unexplained infertility by our IVF department. The baseline 
characteristics of the patients are shown in Table 1. Of 
all the patients, 162 had primary infertility, and 110 had 
secondary infertility. The mean age and mean duration of 
infertility of the patients were similar. Forty-five women in 
the primary infertility group and 27 women in the secondary 
infertility group underwent an IVF/intracytoplasmic sperm 
injection (ICSI) cycle before metroplasty [27.8% (45/162) 
and 24.5% (27/110), respectively] (Table 1). In primary 
infertility group, 45 patients had IVF failures; 23 patients 
had a history of one cycle failure, 16 had two IVF/CSI failure 
cycles, and six patients had 3 IVF/ICSI failure cycles before 
metroplasty. In the secondary infertility group, 27 patients 
had a history of ART failures; 15 women had one IVF/ICSI 
failure, eight patients had two failure cycles, and four had 
three failure cycles. Seven of nine spontaneous pregnancies 
after metroplasty in the primary infertile women group 
had just one IVF failure and two patients had two failed 
IVF/ICSI cycles. In secondary infertile group, the number 
of spontaneous pregnancy after metroplasty in previous 
IVF failure cycles was six, four of which had one previous 
failure and two had 2 IVF/ICSI failures. The CPR and LBR 
after metroplasty are shown in Table 2. In the secondary 
infertility group, the miscarriage rate and ectopic pregnancy 
rate declined dramatically (p=0.01) (Table 2). Nine out of 45 
patients (20%) in the primary infertility group and six out of 
27 patients (22.2%) in the secondary infertility group with a 
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Table 1. Basal characteristics of the study groups
Primary infertility 
(n=162)
Secondary infertility 
(n=110)
p
Age 30.53±4.5 30.41±4.66 0.36
Duration of infertility 5.28±3.54 5.71±3.93 0.84
Previous IVF failure number 27.8% (45/162) 24.5% (27/110) 0.57
Spontaneous LBR after metroplasty 18.5% (30/162) 33.6% (37/110) 0.004
IVF/ICSI LBR after metroplasty 20.4% (33/162) 21.8% (24/110) 0.19
Spontaneous LBR after metroplasty with previous IVF failure 20% (9/45) 22.2% (6/27) 0.52
IVF: In vitro fertilization, ICSI: Intracytoplasmic sperm injection, LBR: Live birth rate
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history of IVF/ICSI failures successfully delivered subsequent 
to metroplasty through spontaneous pregnancies (Table 
1). After metroplasty, the pregnancies of 44 patients in the 
primary infertility group and 24 patients in the secondary 
infertility group were successful with the first fresh IVF/ICSI 
cycle without waiting for spontaneous pregnancy. After the 
second HSG, the time to pregnancy was 5.8±4.7 months in 
the spontaneous pregnancy group and 6.7±5.7 months in 
the pregnancies with ART group (Figure1, 2). The time to 
pregnancy in the primary and secondary infertile groups was 
also similar (Table 2).
Discussion
Our study demonstrated that office hysteroscopic metroplasty 
of dysmorphic uterus might improve fertility, particularly in 
patients with unexplained infertility and with dysmorphic 
uterus, which was an ignored factor previously. Müllerian 
anomalies can impair obstetric outcomes because it can cause 
recurrent pregnancy loss (5-10%), as well as late miscarriage 
and preterm delivery (25%)(9,10). These adverse obstetric 
outcomes may be subsequent to restricted expansion of an 
abnormally small endometrial cavity(11). Increased contractility 
and decreased vascular perfusion of the fibrous uterine septum 
may also contribute(12). We hypothesize that the enlargement 
of the uterine cavity using hysteroscopic metroplasty might 
restore obstetric outcomes by increasing the possibility for 
embryo implantation by proper endometrial vascular perfusion 
together with decreased uterine contractility inducing fragility 
in a dysmorphic uterus. This hypothesis might be supported 
by the majority of metroplasty outcomes of uterine septum 
surgery even in an arcuate uterus in ART cycles(13,14). The 
higher prevalence of previous ectopic pregnancy in women 
with dysmorphic uterus was first reported by Fernandez et 
al.(6). Our study also demonstrated that women with secondary 
infertility with dysmorphic uteri have higher ectopic pregnancy 
rates (15.5%). After correction of the uterine cavity, the ectopic 
pregnancy rate dropped to the expected population. This 
increased rate of ectopic pregnancy might be explained by 
the increased uterine contractility and decreased endometrial 
Table 2. The reproductive outcomes of the secondary infertility group
Preoperative Primary infertility 
(n=162)
Secondary infertility 
(n=110)
p
Pregnancy rate 45.7% (74/162) 55.4% (61/110) -
Miscarriage 84.5% (93/110) 13.5% (10/74) 9.8% (6/61) <0.001
Ectopic pregnancy 15.5% (17/110) 1.4% (1/74) 1.6% (1/61) <0.001
Preterm delivery 0 2.7% (2/74) 0 NS
Term delivery 0 82.4% (61/74) 88.5% (54/61) <0.001
Time to pregnancy (months) - 6.2±3.2 6.3±4.0  0.94
NS: Not significant
Figure 1. Time to spontaneous pregnancy
Figure 2. Time to assisted reproductive technology pregnancy
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implantation in a dysmorphic uterus. Due to a lack of adequate 
and credible data, we did not apply any adhesion prevention 
strategies, such as intrauterine gel or balloon. We evaluated the 
newly-formed cavity configuration using a second HSG and 
hence did not observe any adhesions. We did not encounter any 
complications from hypotonic solution use such as electrolyte 
changes and hyponatremia because we applied saline during 
metroplasty procedures. Throughout the 3 years of the study, 
we did not encounter any complications of hysteroscopy 
such as uterine perforation or excessive bleeding after the 
operation. As expected, there would be no further risk of 
cervical incompetency owing to the thinner hysteroscope, thus 
ruling out the need for cervical dilatation. The major limitation 
of this retrospective study is the absence of the confirmation 
of a narrowed cavity using 3D transvaginal ultrasonography. 
Although our diagnostic criterion was based only on HSG, 
despite HSG being superior for the confirmation of dysmorphic 
uterus, 3D ultrasonography was feasible and appeared to be 
accurate as. If we had the opportunity to evaluate dysmorphic 
uterus using 3D ultrasonography, we would have calculated the 
volume of the endometrial cavity and provided a cut-off volume 
to compare with that of fertile women’s cavities. Although the 
importance of lateral wall thickness in dysmorphic uterus 
was included in the ESHRE/ESGE classification, the definitive 
ratio or thickness in the current literature was not mentioned. 
Furthermore, there is high intra/inter-observer variability in 3D 
ultrasonographic measurements of uterine wall thickness for 
uterine anomalies with conflicting data for their measurements 
owing to the inadequacy of the technique(15). Although the 
ESHRE/ESGE consensus definitive diagnostic criteria were 
demonstrated using the schematic view for dysmorphic uterus, 
we speculate that as a diagnostic tool, the combination of 
HSG and 3D ultrasonography will achieve significantly better 
outcomes, which might be highlighted by future trials. Our 
department is an endoscopic surgery and ART clinic to which 
women who have a potentially higher prevalence of uterine 
anomalies are referred(16). This is why the population ratio in 
this study seemed to be relatively higher. Furthermore, DES 
exposure was not documented in these women due to the 
absence of DES marketing in Turkey. In terms of obstetric 
outcomes, the risk associated with hysteroscopic metroplasty 
of dysmorphic uterus is the potential for placental adhesion 
owing to the possibility of electrosurgical injuries to the 
endometrium and myometrium. We had three different cases 
of placenta accreta that could be related to the intrauterine 
operation during the cesarean process. It is possible to see 
this type of potential adhesion even in the history of cesarean 
procedures conducted to date, hysteroscopic myomectomy, or 
any type of endomyometrial injury. The resultant outcomes at 
our department have been encouraging for fertility expectation 
in women with dysmorphic uterus. The ignored uterine-factor 
infertility must be considered in terms of dysmorphic uterus. 
The relationship between intrauterine adhesion and infertility 
seems to be similar to dysmorphic uterus related to lesser cavity 
volumes(17). Further, the subsiding rate of ectopic pregnancy 
and miscarriage is also optimizing evidence for enlargement of 
dysmorphic cavities. Future randomized controlled trials are 
needed to support the effectiveness of the operation.
Conclusion
Infertile women with dysmorphic uterus should be operated 
by hysteroscope to improve reproductive outcomes. Office 
hysteroscope is an alternative option in terms of non-invasive 
procedure.
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